These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37314950)

  • 1.
    De Hoon I; Boukherroub R; De Smedt SC; Szunerits S; Sauvage F
    Mol Pharm; 2023 Jul; 20(7):3298-3319. PubMed ID: 37314950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and ex vivo corneal penetration and absorption models.
    Agarwal P; Rupenthal ID
    Drug Deliv Transl Res; 2016 Dec; 6(6):634-647. PubMed ID: 26762419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biopharmaceutical evaluation of surface active ophthalmic excipients using in vitro and ex vivo corneal models.
    Juretić M; Cetina-Čižmek B; Filipović-Grčić J; Hafner A; Lovrić J; Pepić I
    Eur J Pharm Sci; 2018 Jul; 120():133-141. PubMed ID: 29702232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression analysis of MDR1, BCRP and MRP3 transporter proteins in different in vitro and ex vivo cornea models for drug absorption studies.
    Verstraelen J; Reichl S
    Int J Pharm; 2013 Jan; 441(1-2):765-75. PubMed ID: 23069916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro cell culture models to study the corneal drug absorption.
    Reichl S; Kölln C; Hahne M; Verstraelen J
    Expert Opin Drug Metab Toxicol; 2011 May; 7(5):559-78. PubMed ID: 21381983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a convenient ex vivo model for the study of the transcorneal permeation of drugs: histological and permeability evaluation.
    Pescina S; Govoni P; Potenza A; Padula C; Santi P; Nicoli S
    J Pharm Sci; 2015 Jan; 104(1):63-71. PubMed ID: 25394188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brinzolamide-loaded nanoemulsions: ex vivo transcorneal permeation, cell viability and ocular irritation tests.
    Mahboobian MM; Seyfoddin A; Aboofazeli R; Foroutan SM; Rupenthal ID
    Pharm Dev Technol; 2019 Jun; 24(5):600-606. PubMed ID: 30472913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and development of a novel pH triggered nanoemulsified in-situ ophthalmic gel of fluconazole: ex-vivo transcorneal permeation, corneal toxicity and irritation testing.
    Pathak MK; Chhabra G; Pathak K
    Drug Dev Ind Pharm; 2013 May; 39(5):780-90. PubMed ID: 22873799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell culture models of the human cornea - a comparative evaluation of their usefulness to determine ocular drug absorption in-vitro.
    Reichl S
    J Pharm Pharmacol; 2008 Mar; 60(3):299-307. PubMed ID: 18284809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human corneal equivalent as cell culture model for in vitro drug permeation studies.
    Reichl S; Bednarz J; Müller-Goymann CC
    Br J Ophthalmol; 2004 Apr; 88(4):560-5. PubMed ID: 15031177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid assessment of ocular drug delivery in a novel ex vivo corneal model.
    Begum G; Leigh T; Courtie E; Moakes R; Butt G; Ahmed Z; Rauz S; Logan A; Blanch RJ
    Sci Rep; 2020 Jul; 10(1):11754. PubMed ID: 32678110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tailored nanostructured platforms for boosting transcorneal permeation: Box-Behnken statistical optimization, comprehensive in vitro, ex vivo and in vivo characterization.
    Elsayed I; Sayed S
    Int J Nanomedicine; 2017; 12():7947-7962. PubMed ID: 29133980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of drug loading and type of ointment base on the in vitro performance of acyclovir ophthalmic ointment.
    Al-Ghabeish M; Xu X; Krishnaiah YS; Rahman Z; Yang Y; Khan MA
    Int J Pharm; 2015 Nov; 495(2):783-91. PubMed ID: 26343911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Approach in Ocular Drug Delivery: In vitro and ex vivo Investigation of Cyclodextrin-Containing, Mucoadhesive Eye Drop Formulations.
    Bíró T; Bocsik A; Jurišić Dukovski B; Gróf I; Lovrić J; Csóka I; Deli MA; Aigner Z
    Drug Des Devel Ther; 2021; 15():351-360. PubMed ID: 33568896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of an organotypic corneal construction as an in vitro model for permeability studies].
    Reichl S; Müller-Goymann CC
    Ophthalmologe; 2001 Sep; 98(9):853-8. PubMed ID: 11594225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of ocular hypotensive agents (PGF2 alpha analogs-bimatoprost, latanoprost, and travoprost) with MDR efflux pumps on the rabbit cornea.
    Hariharan S; Minocha M; Mishra GP; Pal D; Krishna R; Mitra AK
    J Ocul Pharmacol Ther; 2009 Dec; 25(6):487-98. PubMed ID: 20028257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic Ex Vivo Porcine Eye Model to Measure Ophthalmic Drug Penetration under Simulated Lacrimal Flow.
    Barbalho GN; Falcão MA; Lopes JMS; Lopes JM; Contarato JLA; Gelfuso GM; Cunha-Filho M; Gratieri T
    Pharmaceutics; 2023 Sep; 15(9):. PubMed ID: 37765293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pranoprofen quantification in ex vivo corneal and scleral permeation samples: Analytical validation.
    Cañadas-Enrich C; Abrego G; Alvarado HL; Calpena-Campmany AC; Boix-Montañes A
    J Pharm Biomed Anal; 2018 Oct; 160():109-118. PubMed ID: 30077069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a serum-free human cornea construct for in vitro drug absorption studies: the influence of varying cultivation parameters on barrier characteristics.
    Hahne M; Reichl S
    Int J Pharm; 2011 Sep; 416(1):268-79. PubMed ID: 21771646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and ex vivo correlation of drug release from ophthalmic ointments.
    Bao Q; Newman B; Wang Y; Choi S; Burgess DJ
    J Control Release; 2018 Apr; 276():93-101. PubMed ID: 29518465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.